Spots Global Cancer Trial Database for gene
Every month we try and update this database with for gene cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Treatment Resistance Related With Gene Expression Profile of Diffuse Large B-cell Lymphoma | NCT01606605 | Diffuse Large B... | 15 Years - 90 Years | Samsung Medical Center | ||
| Treatment Resistance Related With Gene Expression Profile of Diffuse Large B-cell Lymphoma | NCT01606605 | Diffuse Large B... | 15 Years - 90 Years | Samsung Medical Center | ||
| Extension Neoadjuvant Taxotere: Study of the Effects of Taxotere in Patients With Breast Cancer | NCT00206453 | Breast Cancer | Taxotere | 18 Years - | Baylor Breast Care Center | |
| Safety Assessment of a Multipeptide-gene Vaccine in CML | NCT00455221 | Leukemia, Myelo... | Bcr-abl multipe... Cytokine gene a... | 18 Years - 65 Years | Tehran University of Medical Sciences | |
| Gene-Environment Interaction in Prostate Cancer | NCT00041847 | Prostate Cancer | - 69 Years | National Institute of Environmental Health Sciences (NIEHS) | ||
| Pharmacogenomics IND EXEMPT SNP Clinical Study - Alectinib and Single Nucleotide Polymorphisms | NCT05987956 | Non-small Cell ... | Alectinib - Usu... Alectinib - Stu... | 22 Years - 75 Years | Medicine Invention Design, Inc | |
| Study of the P16 Gene as a Predictor of Myelosuppression in Breast Cancer Patients | NCT01305954 | Breast Cancer | 18 Years - | UNC Lineberger Comprehensive Cancer Center | ||
| Chordoma Family Study | NCT00410670 | Chordoma | 4 Years - 75 Years | National Institutes of Health Clinical Center (CC) | ||
| Cancer Genome Atlas of China:Lung Cancer | NCT04266483 | Non-small Cell ... | - | Xuanwu Hospital, Beijing | ||
| Phase I Study of IV DOTAP: Cholesterol-Fus1 in Non-Small-Cell Lung Cancer | NCT00059605 | Lung Cancer | DOTAP:Chol-fus1 | - | M.D. Anderson Cancer Center | |
| First in Human Study of T3P-Y058-739 (T3P) | NCT05120596 | Advanced Solid ... | Pembrolizumab+T... T3P-Y058-739 (I... T3P-Y058-739 (I... | 18 Years - | T3 Pharmaceuticals AG | |
| Chordoma Family Study | NCT00410670 | Chordoma | 4 Years - 75 Years | National Institutes of Health Clinical Center (CC) | ||
| Genetic Polymorphisms Predict Chemotherapeutic Outcomes in Patients With Metastatic Breast Cancer | NCT01199393 | Breast Neoplasm Drug Therapy Polymorphism,Si... | 18 Years - 75 Years | Peking University Cancer Hospital & Institute | ||
| Molecular Profiling and Molecular Labeling of Inflammatory Myofibroblastic Tumor | NCT04572594 | Inflammatory My... | - | Sun Yat-sen University | ||
| Chordoma Family Study | NCT00410670 | Chordoma | 4 Years - 75 Years | National Institutes of Health Clinical Center (CC) | ||
| Feasibility Study of Genomic Profiling Methods and Timing in Tumor Samples | NCT01703585 | Colorectal Canc... Breast Cancer Gynecological C... Metastatic Eligible for Ph... Melanoma Cancer | 18 Years - | University Health Network, Toronto | ||
| Assessment of EGFR Genomic Alterations as Prognostic Markers in Cervical Cancer | NCT00298064 | Cervical Cancer Cervix | Tissue Reposito... | - | University of New Mexico | |
| First in Human Study of T3P-Y058-739 (T3P) | NCT05120596 | Advanced Solid ... | Pembrolizumab+T... T3P-Y058-739 (I... T3P-Y058-739 (I... | 18 Years - | T3 Pharmaceuticals AG |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
